| Trial ID | NCT06213233 |
| Phase | N/A |
| Status | Recruiting |
| Condition | Pain, Chronic |
| Intervention | Placebo |
Veterans experience disproportionately high rates of chronic pain, often inadequately managed with conventional therapies. This placebo-controlled trial addresses a critical evidence gap by rigorously testing CBD’s analgesic potential in this underserved population.
MIVetsCan is a randomized, placebo-controlled trial evaluating CBD versus placebo for chronic pain management in Veterans. The study is currently recruiting participants and will assess whether CBD can meaningfully improve overall pain symptoms compared to inactive treatment. This represents one of the first dedicated studies examining CBD’s therapeutic potential specifically within the veteran population.
“If positive, this trial could provide the evidence base needed to confidently recommend CBD for veteran chronic pain management. The veteran-specific population makes these results particularly relevant for understanding CBD’s role in complex, treatment-resistant pain syndromes.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
